AQR Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $264M | Sell |
|
|||||
|
2025
Q2 | $272M | Buy |
|
|||||
|
2025
Q1 | $207M | Buy |
|
|||||
|
2024
Q4 | $168M | Sell |
|
|||||
|
2024
Q3 | $163M | Sell |
|
|||||
|
2024
Q2 | $141M | Sell |
|
|||||
|
2024
Q1 | $243M | Sell |
|
|||||
|
2023
Q4 | $313M | Sell |
|
|||||
|
2023
Q3 | $358M | Buy |
|
|||||
|
2023
Q2 | $325M | Buy |
|
|||||
|
2023
Q1 | $287M | Sell |
|
|||||
|
2022
Q4 | $322M | Sell |
|
|||||
|
2022
Q3 | $340M | Sell |
|
|||||
|
2022
Q2 | $376M | Buy |
|
|||||
|
2022
Q1 | $161M | Buy |
|
|||||
|
2021
Q4 | $89.3M | Buy |
|
|||||
|
2021
Q3 | $79.5M | Sell |
|
|||||
|
2021
Q2 | $79M | Sell |
|
|||||
|
2021
Q1 | $127M | Sell |
|
|||||
|
2020
Q4 | $169M | Sell |
|
|||||
|
2020
Q3 | $235M | Sell |
|
|||||
|
2020
Q2 | $353M | Sell |
|
|||||
|
2020
Q1 | $433M | Sell |
|
|||||
|
2019
Q4 | $465M | Buy |
|
|||||
|
2019
Q3 | $287M | Sell |
|
|||||
|
2019
Q2 | $363M | Sell |
|
|||||
|
2019
Q1 | $582M | Buy |
|
|||||
|
2018
Q4 | $542M | Buy |
|
|||||
|
2018
Q3 | $644M | Sell |
|
|||||
|
2018
Q2 | $630M | Sell |
|
|||||
|
2018
Q1 | $803M | Sell |
|
|||||
|
2017
Q4 | $905M | Buy |
|
|||||
|
2017
Q3 | $982M | Buy |
|
|||||
|
2017
Q2 | $618M | Buy |
|
|||||
|
2017
Q1 | $354M | Buy |
|
|||||
|
2016
Q4 | $297M | Sell |
|
|||||
|
2016
Q3 | $329M | Buy |
|
|||||
|
2016
Q2 | $238M | Sell |
|
|||||
|
2016
Q1 | $275M | Sell |
|
|||||
|
2015
Q4 | $402M | Sell |
|
|||||
|
2015
Q3 | $468M | Buy |
|
|||||
|
2015
Q2 | $490M | Buy |
|
|||||
|
2015
Q1 | $404M | Sell |
|
|||||
|
2014
Q4 | $455M | Buy |
|
|||||
|
2014
Q3 | $241M | Buy |
|
|||||
|
2014
Q2 | $80.4M | Sell |
|
|||||
|
2014
Q1 | $96.2M | Buy |
|
|||||
|
2013
Q4 | $69M | Buy |
|
|||||
|
2013
Q3 | $29.5M | Sell |
|
|||||
|
2013
Q2 | $31.4M | Buy |
|